Big Pharma BUSTED: Lawsuits Filed

A child observing colorful pills floating in the air

Texas Attorney General Ken Paxton is taking on Big Pharma giants Johnson & Johnson and Kenvue, alleging they deliberately concealed dangerous links between Tylenol use during pregnancy and autism spectrum disorder in children.

Story Highlights

Texas AG Paxton sues Johnson & Johnson and Kenvue over alleged concealment of Tylenol-autism link
Lawsuit cites 26 epidemiological studies showing positive associations between prenatal acetaminophen use and ASD/ADHD
Companies accused of corporate shell game to dodge liability by transferring risks without assets
Trump administration and RFK Jr. have officially acknowledged the Tylenol-autism connection

Big Pharma’s Decades-Long Deception Exposed

Attorney General Ken Paxton filed a comprehensive lawsuit on October 27 against pharmaceutical giants for allegedly hiding critical health information from American families. The legal action targets Johnson & Johnson and its subsidiaries Kenvue Inc. and Kenvue Brands LLC for concealing the established connection between acetaminophen, Tylenol’s active ingredient, and developmental disorders. The lawsuit represents a significant victory for transparency advocates who have long suspected corporate malfeasance in the pharmaceutical industry.

Scientific Evidence Reveals Corporate Cover-Up

The lawsuit presents damning evidence from 26 epidemiological studies demonstrating positive associations between prenatal acetaminophen use and both autism spectrum disorder and attention deficit hyperactivity disorder. These studies revealed dose-response relationships, meaning higher usage correlated with increased risks to developing children. The pharmaceutical companies allegedly “paid no heed to the scientific facts” by downplaying or actively concealing these established connections from pregnant mothers who trusted their products.

Corporate Shell Game to Dodge Accountability

Beyond concealing health risks, Johnson & Johnson engaged in questionable corporate restructuring to escape legal consequences. The company transferred Tylenol-related liabilities to subsidiary Kenvue without providing adequate assets to handle potential lawsuits. This financial maneuvering represents a calculated attempt to shield the parent company from responsibility while leaving victims without proper recourse. Such corporate tactics exemplify how Big Pharma prioritizes profits over public health and accountability.

Trump Administration Leads Fight for Health Transparency

President Trump and Health Secretary Robert F. Kennedy Jr. have officially recognized the Tylenol-autism link, providing federal backing for state-level accountability efforts. Attorney General Paxton declared that holding Big Pharma accountable for “poisoning our people” will help “Make America Healthy Again.” This coordinated federal-state approach demonstrates the new administration’s commitment to confronting corporate interests that have endangered American families for decades while enriching themselves through deceptive practices.

Corporate Denial Despite Overwhelming Evidence

Despite mounting scientific evidence and legal pressure, both companies maintain their denial of any autism connection. Kenvue claims “independent, sound science clearly shows that taking acetaminophen does not cause autism” and expresses concern about “health risks and confusion” for expecting mothers. Johnson & Johnson attempts to distance itself by claiming it divested its consumer health business years ago, though the lawsuit alleges this divestiture was specifically designed to avoid liability rather than genuine corporate restructuring.